======= FHL1 ======= == Gene Information == * **Official Symbol**: FHL1 * **Official Name**: four and a half LIM domains 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2273|2273]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13642|Q13642]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FHL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FHL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300163|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]. * **UniProt Summary**: N/A |LIM| |regulation of membrane depolarization| |positive regulation of potassium ion transport| |regulation of potassium ion transmembrane transporter activity| |regulation of potassium ion transmembrane transport| |negative regulation of G2/M transition of mitotic cell cycle| |regulation of potassium ion transport| |negative regulation of cell cycle G2/M phase transition| |negative regulation of G1/S transition of mitotic cell cycle| |negative regulation of cell cycle G1/S phase transition| |ion channel binding| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |negative regulation of cell growth| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |negative regulation of cell cycle phase transition| |negative regulation of growth| |regulation of ion transmembrane transporter activity| |regulation of transmembrane transporter activity| |positive regulation of ion transport| |regulation of transporter activity| |muscle organ development| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |regulation of cation transmembrane transport| |regulation of metal ion transport| |regulation of mitotic cell cycle phase transition| |focal adhesion| |regulation of cell growth| |regulation of membrane potential| |regulation of cell cycle phase transition| |muscle structure development| |regulation of ion transmembrane transport| |regulation of transmembrane transport| |negative regulation of cell cycle| |regulation of mitotic cell cycle| |regulation of growth| |regulation of ion transport| |regulation of cell cycle process| |molecular function| |ion homeostasis| |animal organ morphogenesis| |positive regulation of transport| |chemical homeostasis| |regulation of cell cycle| |homeostatic process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp303|39°C R06 exp303]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9454 * **Expression level (log2 read counts)**: 3.77 {{:chemogenomics:nalm6 dist.png?nolink |}}